Back

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

3 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Long term prognosis in coronary artery disease Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Otto Mayer

University Hospital Pilsen, Pilsen (Czechia)

9 More presentations in this session

Presentation thumbnail
Doctor H. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor Y. Gao (Beijing, CN)
Presentation thumbnail
Mr M. Poudel (Bielefeld, DE)
Abstract Slides
Presentation thumbnail
Miss M. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor M. Ferlini (Pavia, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Long term prognosis in coronary artery disease

The Event

Event poster

ESC Congress 2019

3 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study
2 September 2019
thumbnail
Congress Presentation
Mortality data in coronary artery disease: importance of diabetes mellitus and heart failure
20 May 2023
thumbnail
Congress Presentation
Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease
13 April 2024
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources